Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
The receptor-activator of nuclear kappaB ligand (RANKL) signaling pathway plays an important role in the regulation of bone growth and mediates the formation and activation of osteoclasts. Osteoclasts are involved in significant bone resorption and destruction. Denosumab is a fully human monoclonal...
Main Authors: | Tetsuro Yamagishi, Hiroyuki Kawashima, Akira Ogose, Takashi Ariizumi, Taro Sasaki, Hiroshi Hatano, Tetsuo Hotta, Naoto Endo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4862691?pdf=render |
Similar Items
-
The natural history of incidental retroperitoneal schwannomas.
by: Akira Ogose, et al.
Published: (2019-01-01) -
Multinucleation followed by an acytokinetic cell division in myxofibrosarcoma with giant cell proliferation
by: Hotta Tetsuo, et al.
Published: (2009-03-01) -
A malignant solitary fibrous tumour arising from the first lumbar vertebra and mimicking an osteosarcoma: a case report
by: Naoki Oike, et al.
Published: (2017-05-01) -
Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
by: Bahar Miraghazadeh, et al.
Published: (2018-04-01) -
NF-kappaB in Lung Tumorigenesis
by: William N. Rom, et al.
Published: (2011-12-01)